文献速递癫痫

人类癫痫的昼夜与周节律:一项回顾性队列研究

Circadian and circaseptan rhythms in human epilepsy: a retrospective cohort study.
PubMed 文献 · Lancet Neurol · 2018-09-12

该回顾性队列研究利用SeizureTracker和NeuroVista两个数据库,采用圆形统计方法分析癫痫发作的多时间尺度周期。结果显示多数患者存在昼夜节律调制,部分患者存在周节律或更长周期,发作周期具有稳健性和患者特异性。作者认为基于患者个体的发作周期检测与追踪应成为癫痫管理的标准实践。

要点

  • SeizureTracker队列1118例中至少891例(80%)存在昼夜节律调制,NeuroVista队列12例中11例(92%)存在昼夜节律调制。
  • SeizureTracker队列中77例(7%)至233例(21%)存在清晰的7天周期节律,151例(14%)至247例(22%)存在超过3周的显著发作周期。
  • 作者认为发作周期稳健、具有患者特异性且比既往认识更普遍,检测和追踪发作周期应成为癫痫管理的标准实践。

核心结论

  • 研究结果提示癫痫发作周期稳健、具有患者特异性且比既往认识更普遍,与多数癫痫存在昼夜影响的共识一致。
  • 作者认为发作频率变化具有重要临床意义,基于患者个体的发作周期检测与追踪应成为癫痫管理的标准实践。

研究设计与样本

  • 回顾性队列研究,使用SeizureTracker(美国)和NeuroVista(澳大利亚墨尔本)两个人类癫痫发作数据库,采用圆形统计方法分析多时间尺度发作周期。
  • NeuroVista队列纳入难治性局灶性癫痫患者,仅使用至少30次临床发作的患者数据,共12例,数据记录时间为2010年6月10日至2012年8月22日。
  • SeizureTracker参与者为自我选择,数据不遵循特定标准,使用至少100次发作的患者,共1118例,数据记录时间为2007年1月1日至2015年10月19日。
  • 使用平均合成向量长度(R值)衡量多时间尺度发作周期的存在,采用Rayleigh检验和Hodges-Ajne检验检验圆形均匀性,并用蒙特卡洛模拟确认Rayleigh检验的发作相位结果。

主要发现

  • SeizureTracker队列1118例中至少891例(80%)存在昼夜(24小时)发作率调制,NeuroVista队列12例中11例(92%)存在昼夜调制。
  • NeuroVista队列中患者8存在恰好1周的显著周期,患者1和患者7也存在约1周周期,患者1和患者4存在2周周期。
  • SeizureTracker队列1118例中77例(7%)至233例(21%)存在清晰的7天周期强周节律,151例(14%)至247例(22%)存在超过3周的显著发作周期。
  • 发作周期在男性和女性中同样普遍,发作率峰值均匀分布于一周各天。

临床怎么用

  • 作者认为基于患者个体的发作周期检测与追踪应成为癫痫管理的标准实践。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Epilepsy has long been suspected to be governed by cyclic rhythms, with seizure rates rising and falling periodically over weeks, months, or even years. The very long scales of seizure patterns seem to defy natural explanation and have sometimes been attributed to hormonal cycles or environmental factors. This study aimed to quantify the strength and prevalence of seizure cycles at multiple temporal scales across a large cohort of people with epilepsy. METHODS: This retrospective cohort study used the two most comprehensive databases of human seizures (SeizureTracker [USA] and NeuroVista [Melbourne, VIC, Australia]) and analytic techniques from circular statistics to analyse patients with epilepsy for the presence and frequency of multitemporal cycles of seizure activity. NeuroVista patients were selected on the basis of having intractable focal epilepsy; data from patients with at least 30 clinical seizures were used. SeizureTracker participants are self selected and data do not adhere to any specific criteria; we used patients with a minimum of 100 seizures. The presence of seizure cycles over multiple time scales was measured using the mean resultant length (R value). The Rayleigh test and Hodges-Ajne test were used to test for circular uniformity. Monte-Carlo simulations were used to confirm the results of the Rayleigh test for seizure phase. FINDINGS: We used data from 12 people from the NeuroVista study (data recorded from June 10, 2010, to Aug 22, 2012) and 1118 patients from the SeizureTracker database (data recorded from Jan 1, 2007, to Oct 19, 2015). At least 891 (80%) of 1118 patients in the SeizureTracker cohort and 11 (92%) of 12 patients in the NeuroVista cohort showed circadian (24 h) modulation of their seizure rates. In the NeuroVista cohort, patient 8 had a significant cycle at precisely 1 week. Two others (patients 1 and 7) also had approximately 1-week cycles. Patients 1 and 4 had 2-week cycles. In the SeizureTracker cohort, between 77 (7%) and 233 (21%) of the 1118 patients showed strong circaseptan (weekly) rhythms, with a clear 7-day period. Between 151 (14%) and 247 (22%) patients had significant seizure cycles that were longer than 3 weeks. Seizure cycles were equally prevalent in men and women, and peak seizure rates were evenly distributed across all days of the week. INTERPRETATION: Our results suggest that seizure cycles are robust, patient specific, and more widespread than previously understood. They align with the accepted consensus that most epilepsies have some diurnal influence. Variations in seizure rate have important clinical implications. Detection and tracking of seizure cycles on a patient-specific basis should be standard in epilepsy management practices. FUNDING: Australian National Health and Medical Research Council.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Karoly PJ, Goldenholz DM, Freestone DR, et al. Circadian and circaseptan rhythms in human epilepsy: a retrospective cohort study. Lancet Neurol. 2018. PMID: 30219655. doi:10.1016/S1474-4422(18)30274-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。